Displaying 73 - 84 of 122
Viral Hepatitis
2

GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021

View
Metabolism, Alcohol & Toxicity
1

Bristol Myers Squibb: NASH: An evolution in treatment response tools - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Displaying 73 - 84 of 122